Recent advances in the manufacturing technologies have
prompted pharmaceutical companies to consider shifting from the traditional
multi-step, batch manufacturing processes to faster, and relatively more
efficient continuous manufacturing
Roots Analysis is pleased to
announce the publication of its recent study, titled, “Manufacturing Market Continuous
(Small Molecules and Biologics), 2020 – 2030.”
The report features an extensive study of the current
market landscape and future opportunities for companies with capabilities in
continuous manufacturing (both innovator companies with in-house expertise and
contract manufacturers). It features an in-depth analysis, highlighting the
capabilities of various stakeholders engaged in this domain. In addition to
other elements, the study includes:
§
A detailed
assessment of the overall landscape of companies with capabilities for
continuous manufacturing
§ Elaborate
profiles of some of the key contract manufacturers active in the pharmaceutical
and biopharmaceutical continuous manufacturing market
§ An
analysis of the various partnerships related to continuous manufacturing, which
have been established since 2013
§ An
analysis of the expansions related to continuous manufacturing, which have been
established since 2013
§ An
estimate of the global, continuous manufacturing capacity, based on the
capacities of various industry stakeholders (as available on their respective
company websites).
§ A
study of the various grants that have been awarded to research institutes
engaged in projects related to continuous manufacturing, between 2014 and 2019
§ An
in-depth analysis of the various patents that have been filed / granted related
to continuous manufacturing till 2019
§
Initiatives taken by
the leading pharmaceutical companies (in terms of revenues), covering both
partnered as well as in-house projects.
§
A review of the
companies offering modular facilities / modular cleanrooms
§
A case study of the
companies offering technologies / equipment
§
A case study on the
roadmap for the adoption of continuous manufacturing technique
§
A detailed market forecast, featuring analysis of the
current and projected future opportunity across key market segments (listed
below)
§ Purpose
of Manufacturing
§
In-House
§
Contract service
§ Scale
of Operation
§
Commercial
§
Preclinical / Clinical
§ Type
of Continuous Manufacturing related Service
§ API
Manufacturing
§ End
Product manufacturing
§ Type
of Drug Molecule
§
Biologic
§
Small Molecule
§ Type
of dosage form
§
Solid
§
Liquid
§ Key
Geographical Regions
§
North America
§
Europe
§
Asia Pacific
§
Transcripts of
interviews held with the following senior level representatives of stakeholder
companies
§
Andrea Adamo, Founder and Chief Executive Officer, Zaiput
Flow technologies
§
Bayan Takizawa, Co-Founder and Chief Business Officer,
CONTINUUS Pharmaceuticals
§
Nick Thomson, Senior Director Chemical Research and
Development, Pfizer
§
Himanshu Gadgil, Director and Chief Scientific Officer,
Enzene Biosciences
§
Eric Fang, Chief Scientific Officer, Snapdragon Chemistry)
§
Ian Houson, Technical Project Manager, Continuous
Manufacturing and Crystallization, University of Strathclyde
Key
companies covered in the report
- https://www.rootsanalysis.com/reports/308/request-sample.html
§ AbbVie
Contract Manufacturing
§ Ajinomoto
Bio-Pharma Services
§ Almac
§ Boehringer
Ingelheim BioXcellence
§ Cambrex
§ CordonPharma
§ Hovione
§ Kaneka
§ Lonza
§ Patheon
§ SK
biotek
§ WuXi
AppTec
For
more information please click on the following link:
https://www.rootsanalysis.com/reports/view_document/continuous-manufacturing/308.html
Other Offerings
1.
Pharmaceutical Contract Manufacturing
Market (2nd Edition), 2018-2028
2.
Biopharma Contract Manufacturing Market (3rd Edition), 2019 - 2030
3.
China Pharmaceutical Contract Manufacturing Services Market, 2020-2030
4.
China Biopharmaceutical Contract Manufacturing Market, 2020 - 2030
About Roots Analysis
Roots Analysis is one of the fastest growing
market research companies, sharing fresh and independent perspectives in the
bio-pharmaceutical industry. The in-depth research, analysis and insights are
driven by an experienced leadership team which has gained many years of
significant experience in this sector. If you’d like help with your growing
business needs, get in touch at info@rootsanalysis.com
Contact Information
Roots
Analysis Private Limited
Gaurav Chaudhary
+1 (415) 800 3415
Facebook - https://www.facebook.com/RootsAnalysis
LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
Twitter - https://twitter.com/RootsAnalysis
Comments
Post a Comment